Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP

Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP

ByKaushiki

Mankind Pharma’s stock increased 2.3% during trading, reaching an intraday high of Rs 2,753 on the BSE. A day after the company’s qualified institutional placement (QIP) was launched, the stock was purchased at a floor price of Rs 2,616.55 per share. This is a 2.4% reduction from the closing price on Monday. According to its…

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs

Mankind Pharma pledges 39.68% stake in Bharat Serums to secure ₹5,000 crore NCDs

ByKaushiki

Bharat Serums and Vaccines Limited (BSV), a fully-owned subsidiary of Mankind Pharma Limited, has pledged 39.68 per cent of its equity stake to secure non-convertible debentures (NCDs) worth ₹5,000 crores. As the common security trustee for these NCDs, Catalyst Trusteeship Limited was designated by SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015. The share price…